Fagron (ENXTBR:FAGR) shareholders approved all resolutions at the Annual and Extraordinary General Meetings. The meetings ...

Fagron agreed to pay $22.05 million to resolve allegations that its subsidiary, Freedom Pharmaceuticals, intentionally inflated average wholesale prices for its ingredients to increase reimbursements ...

Fagron is recalling all unexpired lots of its topical anesthesia that was distributed nationwide to hospitals, pharmacies and distributors after the FDA found possible bacterial contamination. The non ...

May 2026 – 6PM CET Fagron shareholders approve all proposed resolutions at the General Meetings Fagron, the leading global ...

Add Yahoo as a preferred source to see more of our stories on Google. WASHINGTON (Reuters) - Pharmaceutical supplier Fagron Holding USA LLC will pay $22.5 million to resolve allegations that its ...

Fagron, the leading global player in pharmaceutical compounding, announces that the Brazilian competition authority, CADE, has granted clearance for the previously announced acquisitions of Purifarma ...

Fagron, the leading global player in pharmaceutical compounding is pleased to announce the signing of two strategic acquisitions: CareFirst Specialty Pharmacy in North America and Injeplast in Brazil.

WICHITA, Kan., March 17, 2026 /PRNewswire/ -- Fagron Sterile Services (FSS) today announced a major milestone in strengthening the nation's supply of critical injectable medicines, with its Sterile ...

Fagron, the leading global player in pharmaceutical compounding, announces the successful completion of its acquisition of Vepakum in Latin America. The transaction, announced in December 2025, was ...

Fagron, the leading global player in pharmaceutical compounding, is pleased to announce a strategic acquisition that will significantly reinforce its presence in North America. The company has signed ...

Rafael Padilla, CEO of Fagron: “I am incredibly pleased with the performance we delivered in 2025. Growth was broad-based across regions and segments, supported by our diversified model, disciplined ...

PHOENIX--(BUSINESS WIRE)--Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D pharmaceutical printing, delivery systems, and ...